Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan

Ruwen Jou, C. Y. Chiang, C. Y. Yu, M. H. Wu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the impact of external quality assessment on the quality of drug susceptibility testing (DST) in clinical mycobacteriology laboratories. DESIGN: A pilot evaluation of DST proficiency was conducted in 2006 and scaled up in 2007. A panel consisting of 20 Mycobacterium tuberculosis isolates was used. Accuracy of 95% in detecting resistance to both isoniazid (INH) and rifampicin (RMP), and 90% to both ethambutol (EMB) and streptomycin (SM), was used to define a competent laboratory. RESULTS: Nine laboratories participated in 2006 and 30 in 2007. In 2006, the mean accuracy in detecting resistance to INH was 91.6%, for RMP it was 96.1%, for EMB it was 90.5% and for SM it was 93.9%. In 2007, the mean accuracy in detecting resistance to INH increased to 95.7% and that for RMP to 97.2%, while the accuracy of EMB resistance detection decreased to 82.0% and that for SM resistance to 86.8%. Quality improvement was observed in those laboratories that had adopted standardised methods. Overall, only five (17%) laboratories fulfilled the competency criteria for all four drugs in 2007. CONCLUSION: The majority of the laboratories that participated in 2006 demonstrated an improvement in DST performance in 2007. It is essential to continue external quality assessment to strengthen the quality of DST.

Original languageEnglish
Pages (from-to)1142-1147
Number of pages6
JournalInternational Journal of Tuberculosis and Lung Disease
Volume13
Issue number9
Publication statusPublished - Sep 2009
Externally publishedYes

Fingerprint

Taiwan
Mycobacterium tuberculosis
Ethambutol
Streptomycin
Rifampin
Pharmaceutical Preparations
Drug Evaluation
Isoniazid
Quality Improvement

Keywords

  • Drug susceptibility testing
  • Proficiency
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan. / Jou, Ruwen; Chiang, C. Y.; Yu, C. Y.; Wu, M. H.

In: International Journal of Tuberculosis and Lung Disease, Vol. 13, No. 9, 09.2009, p. 1142-1147.

Research output: Contribution to journalArticle

@article{d0ff952d9e944113809ea2f06fffdf74,
title = "Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan",
abstract = "OBJECTIVE: To evaluate the impact of external quality assessment on the quality of drug susceptibility testing (DST) in clinical mycobacteriology laboratories. DESIGN: A pilot evaluation of DST proficiency was conducted in 2006 and scaled up in 2007. A panel consisting of 20 Mycobacterium tuberculosis isolates was used. Accuracy of 95{\%} in detecting resistance to both isoniazid (INH) and rifampicin (RMP), and 90{\%} to both ethambutol (EMB) and streptomycin (SM), was used to define a competent laboratory. RESULTS: Nine laboratories participated in 2006 and 30 in 2007. In 2006, the mean accuracy in detecting resistance to INH was 91.6{\%}, for RMP it was 96.1{\%}, for EMB it was 90.5{\%} and for SM it was 93.9{\%}. In 2007, the mean accuracy in detecting resistance to INH increased to 95.7{\%} and that for RMP to 97.2{\%}, while the accuracy of EMB resistance detection decreased to 82.0{\%} and that for SM resistance to 86.8{\%}. Quality improvement was observed in those laboratories that had adopted standardised methods. Overall, only five (17{\%}) laboratories fulfilled the competency criteria for all four drugs in 2007. CONCLUSION: The majority of the laboratories that participated in 2006 demonstrated an improvement in DST performance in 2007. It is essential to continue external quality assessment to strengthen the quality of DST.",
keywords = "Drug susceptibility testing, Proficiency, Tuberculosis",
author = "Ruwen Jou and Chiang, {C. Y.} and Yu, {C. Y.} and Wu, {M. H.}",
year = "2009",
month = "9",
language = "English",
volume = "13",
pages = "1142--1147",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "9",

}

TY - JOUR

T1 - Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan

AU - Jou, Ruwen

AU - Chiang, C. Y.

AU - Yu, C. Y.

AU - Wu, M. H.

PY - 2009/9

Y1 - 2009/9

N2 - OBJECTIVE: To evaluate the impact of external quality assessment on the quality of drug susceptibility testing (DST) in clinical mycobacteriology laboratories. DESIGN: A pilot evaluation of DST proficiency was conducted in 2006 and scaled up in 2007. A panel consisting of 20 Mycobacterium tuberculosis isolates was used. Accuracy of 95% in detecting resistance to both isoniazid (INH) and rifampicin (RMP), and 90% to both ethambutol (EMB) and streptomycin (SM), was used to define a competent laboratory. RESULTS: Nine laboratories participated in 2006 and 30 in 2007. In 2006, the mean accuracy in detecting resistance to INH was 91.6%, for RMP it was 96.1%, for EMB it was 90.5% and for SM it was 93.9%. In 2007, the mean accuracy in detecting resistance to INH increased to 95.7% and that for RMP to 97.2%, while the accuracy of EMB resistance detection decreased to 82.0% and that for SM resistance to 86.8%. Quality improvement was observed in those laboratories that had adopted standardised methods. Overall, only five (17%) laboratories fulfilled the competency criteria for all four drugs in 2007. CONCLUSION: The majority of the laboratories that participated in 2006 demonstrated an improvement in DST performance in 2007. It is essential to continue external quality assessment to strengthen the quality of DST.

AB - OBJECTIVE: To evaluate the impact of external quality assessment on the quality of drug susceptibility testing (DST) in clinical mycobacteriology laboratories. DESIGN: A pilot evaluation of DST proficiency was conducted in 2006 and scaled up in 2007. A panel consisting of 20 Mycobacterium tuberculosis isolates was used. Accuracy of 95% in detecting resistance to both isoniazid (INH) and rifampicin (RMP), and 90% to both ethambutol (EMB) and streptomycin (SM), was used to define a competent laboratory. RESULTS: Nine laboratories participated in 2006 and 30 in 2007. In 2006, the mean accuracy in detecting resistance to INH was 91.6%, for RMP it was 96.1%, for EMB it was 90.5% and for SM it was 93.9%. In 2007, the mean accuracy in detecting resistance to INH increased to 95.7% and that for RMP to 97.2%, while the accuracy of EMB resistance detection decreased to 82.0% and that for SM resistance to 86.8%. Quality improvement was observed in those laboratories that had adopted standardised methods. Overall, only five (17%) laboratories fulfilled the competency criteria for all four drugs in 2007. CONCLUSION: The majority of the laboratories that participated in 2006 demonstrated an improvement in DST performance in 2007. It is essential to continue external quality assessment to strengthen the quality of DST.

KW - Drug susceptibility testing

KW - Proficiency

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=70349218301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349218301&partnerID=8YFLogxK

M3 - Article

C2 - 19723405

AN - SCOPUS:70349218301

VL - 13

SP - 1142

EP - 1147

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 9

ER -